Workflow Integration Determines Whether GPs Use Telepharmacological Polypharmacy Consultation

This small qualitative study shows pharmacists building cross-sectoral polypharmacy services that referral friction, awareness and time pressure, not doubts about clinical value, drive uptake by general practitioners.

📅 Journal publication: Nov 2026 · Last updated: Oct 19, 2026

telepharmacologypolypharmacymultimorbiditygeneral practitionersclinical pharmacologyqualitative studythematic analysiscross-sectoral coordinationgeriatricsdeprescribingprimary careimplementation Clinical Pharmacy Practice

Also in Ambulatory Care / MTM

Background Information

Can telepharmacy transform polypharmacy management for complex patients?

Telepharmacological services can enhance polypharmacy management and improve care coordination for complex elderly patients. Integration into clinical software is crucial for uptake, and GPs can apply learnings beyond individual patients. This qualitative study highlights potential barriers and facilitators for implementing telepharmacology in primary care settings, though findings are region-specific. Telepharmacy improves polypharmacy management if well-integrated into existing GP workflows.

📊 Deep Analysis Available

Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.

Subscribe for Full Access →

Authors: Henriksen DP

Citation: Henriksen DP Telepharmacological Consultation for Polypharmacy Management in Primary Care: A Qualitative Study of General Practitioners' Experiences With Cross-Sectoral Coordination. Basic & clinical pharmacology & toxicology. 2026;139(5):e70325. doi:10.1111/bcpt.70325

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓

Reviewed by a licensed pharmacist

Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.

Accurate and up-to-date information is our highest priority.

If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.

Suggest a correction Request a topic

Thanks for the feedback!

🔒

Deep Analysis: Subscribers Only

Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.

Executive Summary

Study Design

Patient Population

Primary Outcomes

Secondary Outcomes & Safety Profile

Pharmacist Implications

Clinical Pearls

Limitations

Controversies & Evidence Gaps

Cost & Logistics

Want the full analysis?

Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.

Become a Subscriber →